Lupus Therapeutic Market Is Estimated To Witness High Growth Owing To Increasing Disease Prevalence
lupus therapeutic The lupus therapeutic market is estimated to be valued at US$ 3035.59 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Lupus therapeutic products are used for the treatment of systemic lupus erythematosus (SLE), commonly known as lupus. SLE is a chronic autoimmune disease that causes inflammation and tissue damage in various parts of the body including joints, skin kidneys, blood cells, brain, heart and lungs. The disease affects approximately 1.5 million people in the U.S. and drugs therapies help reduce disease symptoms and organ damage. Market Dynamics: The lupus therapeutic market is driven by increasing prevalence of SLE globally. According to estimates, around 1.5 million Americans and at least 5 million people worldwide have lupus. It is most common in women aged 15 to 44, with 90% of people with the disease being women. ...